Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It was aimed at limaliam on this thread, but it has been relentless all week on all threads to.
In the short to medium term SNG001 is a fantastic agnostic insurance policy for viral defence globally that's for sure (big economic downside protection policy) so I'm waiting patiently for the commercial and governmental traction to build...whether that's catalysed by ACTIV2 ++decisions and other freebie trials or interested parties wanting a licensing deal or a buy out..it will happen
Thanks for sharing Tommy. I wonder how long a platform trial would take, what level of priority SNG001 would receive and the required sample size to make sure trial is robust with no chance of it being underpowered etc.
AJ think your on the wrong thread, all that is on this thread is praise for RM and congratulating him on a great interview!
Well he definitely seems happy and not worried, with £25m still in the bank there is nothing really to worry about for another few years. No mention of any engagement with the regulator for the next step, and the talk seemed to be around helping people in the hospital. Well if you really want to help the 300 odd people dying everyday the first thing would be to apply for an EUA urgently. Leave it to the regulators to decide if the deep dive data is good enough for an EUA, don't pre decide yourself.
This board is full of little *****ing sissy’s. Does my head in reading some of moaning of grown men. People are expecting way to much. They got the good dd data and presented it really well this week, RM has been on the ground networking and doing his job despite days of speculation he was floating around on his boat. They are updating next week which was RNS’d way in advance so anyone with a brain would expect them to give us updates on what next there. Everyone needs some perspective here and some respect instead of acting like spoilt kids at Christmas. Save all the moaning until after the scheduled update.
Most upbeat I have seen him and clearly very happy with his 1/3rd of DD patients responding with 70% improvement
Alluding to a number of conversations that have taken place at ATS....so RM has been doing his job networking and having these meetings and by the sounds of it the teams found it 'very interesting'!
Also will he please stop smirking in this video.....its making me want to buy more!
Getting us on a platform trial plus positive Activ2 data may well be more than a slow burner for interest from Big Pharma and from regulator’s
Yes, he has his Jeremy Clarkson face on which has always been a good sign.
I'm a little annoyed that after syating some of the subgroups that they looked at didn't have statistical significance he then failed to state that the data from the best performing group did have statistical significance. A bit of a **** up.
But if they come back quickly with an update about being added to a platform trial or two I'll forgive him.
He doesn't tell lies or exaggerate (that'shis failing really), so more than one trial is 'very interested' in the product.
**** sake marsden get it done!
this is definitely shaping up to be a slow burner. At least it's put any questions about a fund raise to bed for now
Thanks Tommy RM looks VERY HAPPY :)
YouTube